Niveditha Nerlakanti

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Histone Deacetylase

Bone Mineral Density

Top Venues

Nature communications

Molecular cancer therapeutics

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan T Bishop, Anna K Miller, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S Frieling, Mostafa M Nasr, Karl J Nyman, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Ariosto Siqueira Silva, Kenneth H Shain, Conor C Lynch, David Basanta
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Nature communications 15 (1) (2024)
Ryan T Bishop, Anna K Miller, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S Frieling, Mostafa M Nasr, Karl J Nyman, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Ariosto Siqueira Silva, Kenneth H Shain, Conor C Lynch, David Basanta
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Nature communications 15 (1) (2024)
Ryan T Bishop, Anna K Miller, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S Frieling, Mostafa M Nasr, Karl J Nyman, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Ariosto Siqueira Silva, Kenneth H Shain, Conor C Lynch, David Basanta
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Nature communications 15 (1) (2024)
Ryan T Bishop, Anna K Miller, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S Frieling, Mostafa M Nasr, Karl J Nyman, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Ariosto Siqueira Silva, Kenneth H Shain, Conor C Lynch, David Basanta
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Nature communications 15 (1) (2024)
Jeremy J McGuire, Niveditha Nerlakanti, Chen Hao Lo, Marilena Tauro, Thomas J Utset-Ward, Damon R Reed, Conor C Lynch
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma. International journal of cancer 147 (10) (2020)
Leah M Cook, Jeremy S Frieling, Niveditha Nerlakanti, Jeremy J McGuire, Paul Allen Stewart, Karen L Burger, John L Cleveland, Conor C Lynch
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene 38 (44) (2019)
Niveditha Nerlakanti, Jiqiang Yao, Duy T Nguyen, Ami K Patel, Alexey M Eroshkin, Harshani R Lawrence, Muhammad Ayaz, Brent M Kuenzi, Neha Agarwal, Yunyun Chen, Steven Gunawan, Rezaul Md Karim, Norbert Berndt, John Puskas, Anthony M Magliocco, Domenico Coppola, Jasreman Dhillon, Jingsong Zhang, Subramaniam Shymalagovindarajan, Uwe Rix, Youngchul Kim, Ranjan Perera, Nicholas J Lawrence, Ernst Schonbrunn, Kiran Mahajan
Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 17 (12) (2018)